Navigation Links
Nile Therapeutics Completes Dosing of Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide in Chronic Heart Failure Patients
Date:10/18/2011

he next trial," said Hsiao Lieu, MD, Vice President of Clinical Research at Nile. "We believe we understand cenderitide's pharmacokinetics and pharmacodynamics when administered through continuous subcutaneous infusion, and look forward to moving into the next phase of development."

"We are very encouraged by the data we have seen to date," said Joshua Kazam, Chief Executive Officer of Nile. "We are currently actively engaged in discussions with potential strategic and financial partners to ensure that we determine the best way to move forward with this exciting program in the best interests of our shareholders."

About Heart Failure

Heart failure is the fastest-growing clinical cardiac disease in the U.S. according to the American Heart Association, affecting over 5 million Americans. Over 1 million patients in the U.S. each year are hospitalized with ADHF, an acute exacerbation of heart failure. ADHF is the is the most frequent cause of hospital admission in the U.S. for patients older than 65 years, generating annual inpatient costs of more than $35 billion. Within 90 days following admission for ADHF, approximately 40% of patients return to the hospital. Nile believes that a decrease in the ADHF re-hospitalization rate, which is the clinical target of the cenderitide development program, could both improve the quality of life for patients and decrease the annual inpatient cost of heart failure.

About Nile Therapeutics

Nile Therapeutics, Inc. is a biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developing its lead compound, cenderitide, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure, and CU-NP, a novel rationally designed natriuretic peptide. More information on Nile can be found at http://
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... , Nov. 27, 2014 ... to Academic Research - JIN Co., Ltd. will ... a market price of 500,000 yen or $5,000 (without tax ... software). The "ACADEMIC PACK" is a dedicated solution of "JINS ... capture and analyze deep data* generated by electrooculography and six-axis ...
(Date:11/26/2014)... -- Cohen, Placitella & Roth, PC is investigating potential ... Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 2011 through November 2, 2014 ("Class Period").  The ... officers and directors publically disseminated materially false and/or ... 20(a) of the Securities Exchange Act of 1934 ...
(Date:11/26/2014)... Md. , Nov. 26, 2014  Over 100 ... of those suffer from this pain daily. Chronic and ... of pain management is born to fulfill the need ... all types of pain. On October 28th, ... the Cumberland, Maryland community.  This ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3New Pain Management Center Opens in Cumberland, Md. 2
... Inc. (NYSE: MTD ) today announced the webcast ... in New York on Wednesday, September 21, 2011, at 9:00 ... presentation, visit the investor relations page on the Company,s Web ... will be available for seven days. METTLER TOLEDO ...
... Micross Components, a leading global provider of ... Manager of its US Products & Services Division. ... business development, will play a leading role in ... to increase market share across several key business ...
Cached Medicine Technology:Micross Components Names Mike Deley as General Manager of US Products & Services Division 2
(Date:11/27/2014)... TORQ Cycle is not only know for their highly ... the way to help their customers but also for their ... their workouts sincerely using indoor cycling . They have ... is important for people to take their fitness quite seriously. ... that people take to fitness and are encouraged to work ...
(Date:11/27/2014)... Let the Black Friday sales begin at Sublime Beauty®! ... filled with skincare goodies, will delight and please her on ... last - no coupon required. See the gift ... Amazon at the same sales prices. Links to the Amazon ... ease. , The company published a 2014 Gift Guide ...
(Date:11/27/2014)... 2014 Luciana Lagana and her ... of Omadox, a feature film that received 9 awards at ... best ensemble cast. It is also an official selection of ... to a successful cinematic career for James Noel, a young ... you enjoy experimental mystery, filmed in glorious black and white, ...
(Date:11/27/2014)... Blood-borne pathogens raise the risk of spreading ... in place to counter this. However, it doesn’t seem ... with menstrual blood are taken as seriously. , ... way to handle tampons and menstrual pads while also ... , He then created a prototype of the Sani-M, ...
(Date:11/27/2014)... York, New York (PRWEB) November 27, 2014 ... ) have been filed in a consolidated ... Liebhard LLP reports. , Documents recently updated ... 1,079 records included in the state proceeding, all ... schizophrenia, bipolar disorder and other psychiatric conditions. Many ...
Breaking Medicine News(10 mins):Health News:The new wave in Fitness : Stay Active with Innovative Indoor Cycling Programs 2Health News:Big Christmas Sales Begin Today at Sublime Beauty® for all Christmas Gift Selections and Skincare Sets 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4
... study finds , , WEDNESDAY, March 4 (HealthDay News) -- ... with accompanying commercials for alcohol were more apt to grab ... to those who watched a movie without the drinking prompts. ... effect of on-screen depictions of alcohol and their influence on ...
... Growth From World,s Largest EconomyMISSISSAUGA, ON, March 4 /PRNewswire-FirstCall/ ... developing drug free, non-invasive low level laser and light ... that the company has received CE Mark approval to ... light products in all 25 European Union (EU) and ...
... and their dogsNEW YORK, March 4 ... initiative to help dogs and their owners become more fit ... enjoy the benefits their dogs bring to their lives, the ... further this enjoyment. The "Walk Your Dog, Make Life ...
... advanced telemedicine program in the state, proven to ... and improve patient outcomesANCHORAGE, Alaska, March 4, 2009 ... new program to enhance care of the critically ... eICU(R) Program, patented by Philips VISICU, combines early ...
... Kournikova has just returned from her first visit ... effects of years of poverty, violence and natural ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090304/DC78519 )"It was ... said Kournikova, following her visit. "This trip ...
... as Co-Founder of MISSION Skincare(TM) NEW YORK, March 4 ... Athlete-Engineered Skincare(TM) products, is pleased to announce that champion ... Skincare(TM) products are designed and tested by the world,s ... training and competition as well as the everyday needs ...
Cached Medicine News:Health News:Media Images of Alcohol Can Drive You to Drink 2Health News:MedX Health Receives CE Mark for Laser & Light Products 2Health News:MedX Health Receives CE Mark for Laser & Light Products 3Health News:Shape Partners With Iams to Create Healthy Living Program 'Walk Your Dog, Make Life Better' 2Health News:eICU(R) Program Activates in Alaska 2Health News:eICU(R) Program Activates in Alaska 3Health News:PSI Brings Tennis Star Anna Kournikova to Haiti Bringing Hope and Assistance to Child Slaves 2Health News:PSI Brings Tennis Star Anna Kournikova to Haiti Bringing Hope and Assistance to Child Slaves 3Health News:Sergio Garcia Has a New 'MISSION' 2
Tungsten Carbide wire twister....
Large solid mallet with patented Ortho-Grip® silicone rubber handle....
Straight chisel for scoring, cutting, scraping, cleaning and sculpting bone....
Custom-made chisels....
Medicine Products: